Published data suggest that CB1R activation in hepatic tissue causes steatosis due to upregulated lipogenesis [11, 18, 20, 33] and reduced FA oxidation [11, 33], and the opposite occurs by CB1R blockade [33, 34]. The gene discussed is CNR1; the disease is steatosis.